Business Context and Reporting Period
This Form 8-K filing by HealthEquity, Inc. (HQY) is dated November 11, 2024, with the report date of November 12, 2024. The filing discloses significant changes in executive leadership and board composition, specifically the retirement of the current CEO and the appointment of a successor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements and transition terms.
Material Changes
- CEO Transition: Jon Kessler, President and CEO, will retire from employment effective January 6, 2025, and from the Board of Directors effective April 30, 2025. He will serve as a Special Advisor until April 30, 2025.
- New CEO Appointment: Scott R. Cutler was appointed President and CEO, effective January 6, 2025. He was also appointed to the Board of Directors, expanding the board size to eleven members.
- Compensation Structure:
- Scott Cutler: Base salary of at least $775,000; target annual bonus of 100% of base salary; $650,000 sign-on bonus (repayable under specific conditions); and an initial equity award of $7,500,000 in RSUs vesting over three years.
- Jon Kessler: Base salary of $750,000 remains unchanged during the Special Advisor period. He remains eligible for annual bonuses. Specific provisions allow for pro-rated bonuses and continued vesting of performance-based RSUs under qualifying retirement conditions.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business strategy. The primary risk disclosed relates to the leadership transition and the associated financial obligations for severance and retention packages. The filing notes that Mr. Kessler's retirement is not due to any disagreement with the Company.
Investor Verification Checklist
- Verify the exact effective dates for the CEO transition (January 6, 2025) and the Board departure (April 30, 2025).
- Review the full text of the Employment Agreement (Exhibit 10.1) and Transition Agreement (Exhibit 10.3) for detailed definitions of "cause," "good reason," and change in control provisions.
- Confirm the vesting schedule and performance metrics for the $7.5 million RSU grant to Mr. Cutler.
- Assess the impact of the $650,000 sign-on bonus and potential severance payments on near-term cash flow and stock-based compensation expenses.
- Monitor the press release (Exhibit 99.1) for additional context on the strategic rationale for the leadership change.